174 related articles for article (PubMed ID: 32652500)
1. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract][Full Text] [Related]
4. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
5. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
[TBL] [Abstract][Full Text] [Related]
6. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
7. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.
Chen Y; Zhao B; Wang X
BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099
[TBL] [Abstract][Full Text] [Related]
9. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
Lu G; Chen L; Wu S; Feng Y; Lin T
Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index in germ-cell tumours.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Kalavska K; Rejlekova K; Svetlovska D; Macak D; Spanik S; Kajo K; Babal P; De Giorgi U; Mego M; Mardiak J
Br J Cancer; 2018 Mar; 118(6):831-838. PubMed ID: 29485980
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.
Wu Y; Meyers JP; Shi G; Jin Z; Xia J; Gu Y; Qian Q; Hong Y
J Surg Oncol; 2019 Sep; 120(3):508-517. PubMed ID: 31140623
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy.
Fankhauser CD; Sander S; Roth L; Gross O; Eberli D; Sulser T; Seifert B; Beyer J; Hermanns T
Br J Cancer; 2018 Mar; 118(6):825-830. PubMed ID: 29485982
[TBL] [Abstract][Full Text] [Related]
18. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients.
Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
[TBL] [Abstract][Full Text] [Related]
19. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
[TBL] [Abstract][Full Text] [Related]
20. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
Gao F; Xu Q; Jiang Y; Lu B
Sci Rep; 2023 Mar; 13(1):3759. PubMed ID: 36882567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
